nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ORM1—Quinidine—malaria	0.116	0.161	CbGbCtD
Vemurafenib—CYP3A4—Clindamycin—malaria	0.0591	0.0818	CbGbCtD
Vemurafenib—CYP2D6—Pyrimethamine—malaria	0.0533	0.0739	CbGbCtD
Vemurafenib—CYP1A2—Proguanil—malaria	0.0518	0.0717	CbGbCtD
Vemurafenib—CYP2D6—Artemether—malaria	0.0454	0.0628	CbGbCtD
Vemurafenib—CYP2D6—Proguanil—malaria	0.0426	0.0591	CbGbCtD
Vemurafenib—CYP2D6—Quinidine barbiturate—malaria	0.0404	0.056	CbGbCtD
Vemurafenib—CYP1A2—Pentoxifylline—malaria	0.0372	0.0515	CbGbCtD
Vemurafenib—CYP3A4—Sulfadiazine—malaria	0.0339	0.047	CbGbCtD
Vemurafenib—CYP1A2—Quinine—malaria	0.0333	0.0462	CbGbCtD
Vemurafenib—CYP1A2—Quinidine—malaria	0.0293	0.0406	CbGbCtD
Vemurafenib—CYP3A4—Artemether—malaria	0.0288	0.0399	CbGbCtD
Vemurafenib—CYP2D6—Quinine—malaria	0.0275	0.0381	CbGbCtD
Vemurafenib—CYP3A4—Proguanil—malaria	0.0271	0.0376	CbGbCtD
Vemurafenib—CYP3A4—Doxycycline—malaria	0.0257	0.0356	CbGbCtD
Vemurafenib—CYP2D6—Quinidine—malaria	0.0241	0.0334	CbGbCtD
Vemurafenib—CYP3A4—Quinine—malaria	0.0175	0.0242	CbGbCtD
Vemurafenib—CYP3A4—Quinidine—malaria	0.0154	0.0213	CbGbCtD
Vemurafenib—CYP3A4—Dapsone—malaria	0.0132	0.0183	CbGbCtD
Vemurafenib—ORM1—saliva—malaria	0.0089	0.132	CbGeAlD
Vemurafenib—Sunburn—Clindamycin—malaria	0.00549	0.0379	CcSEcCtD
Vemurafenib—RAF1—saliva-secreting gland—malaria	0.00325	0.048	CbGeAlD
Vemurafenib—RAF1—hematopoietic system—malaria	0.0031	0.0459	CbGeAlD
Vemurafenib—BRAF—blood—malaria	0.00309	0.0456	CbGeAlD
Vemurafenib—BRAF—bone marrow—malaria	0.00299	0.0441	CbGeAlD
Vemurafenib—Toxic epidermal necrolysis—Pyrimethamine—malaria	0.00282	0.0194	CcSEcCtD
Vemurafenib—Folliculitis—Clindamycin—malaria	0.00264	0.0182	CcSEcCtD
Vemurafenib—RAF1—kidney—malaria	0.00254	0.0376	CbGeAlD
Vemurafenib—BRAF—liver—malaria	0.00241	0.0357	CbGeAlD
Vemurafenib—Stevens-Johnson syndrome—Pyrimethamine—malaria	0.00239	0.0165	CcSEcCtD
Vemurafenib—CYP1A2—blood plasma—malaria	0.00223	0.033	CbGeAlD
Vemurafenib—RAF1—digestive system—malaria	0.00216	0.0319	CbGeAlD
Vemurafenib—ORM1—hematopoietic system—malaria	0.00214	0.0317	CbGeAlD
Vemurafenib—Hepatotoxicity—Quinidine—malaria	0.00211	0.0145	CcSEcCtD
Vemurafenib—Hepatotoxicity—Quinine—malaria	0.00211	0.0145	CcSEcCtD
Vemurafenib—RAF1—blood—malaria	0.00206	0.0304	CbGeAlD
Vemurafenib—Erythema multiforme—Pyrimethamine—malaria	0.00205	0.0141	CcSEcCtD
Vemurafenib—RAF1—bone marrow—malaria	0.00199	0.0294	CbGeAlD
Vemurafenib—BRAF—brain—malaria	0.00191	0.0283	CbGeAlD
Vemurafenib—Hepatotoxicity—Quinidine barbiturate—malaria	0.0019	0.0131	CcSEcCtD
Vemurafenib—CYP3A4—blood plasma—malaria	0.00162	0.0239	CbGeAlD
Vemurafenib—RAF1—liver—malaria	0.00161	0.0238	CbGeAlD
Vemurafenib—CYP2D6—blood plasma—malaria	0.00159	0.0235	CbGeAlD
Vemurafenib—Anaphylactic shock—Pyrimethamine—malaria	0.00154	0.0106	CcSEcCtD
Vemurafenib—Mediastinal disorder—Proguanil—malaria	0.00152	0.0105	CcSEcCtD
Vemurafenib—Rash maculo-papular—Clindamycin—malaria	0.00151	0.0104	CcSEcCtD
Vemurafenib—Malnutrition—Proguanil—malaria	0.00147	0.0101	CcSEcCtD
Vemurafenib—Erythema—Proguanil—malaria	0.00147	0.0101	CcSEcCtD
Vemurafenib—Toxic epidermal necrolysis—Sulfadiazine—malaria	0.00146	0.01	CcSEcCtD
Vemurafenib—ORM1—blood—malaria	0.00142	0.021	CbGeAlD
Vemurafenib—ORM1—bone marrow—malaria	0.00137	0.0203	CbGeAlD
Vemurafenib—Photosensitivity—Quinidine—malaria	0.00135	0.00928	CcSEcCtD
Vemurafenib—Photosensitivity—Quinine—malaria	0.00135	0.00928	CcSEcCtD
Vemurafenib—ABCG2—saliva-secreting gland—malaria	0.00135	0.0199	CbGeAlD
Vemurafenib—Decreased appetite—Pyrimethamine—malaria	0.00134	0.00922	CcSEcCtD
Vemurafenib—Cough—Proguanil—malaria	0.00128	0.00883	CcSEcCtD
Vemurafenib—RAF1—brain—malaria	0.00128	0.0189	CbGeAlD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00124	0.00856	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Sulfadiazine—malaria	0.00124	0.00852	CcSEcCtD
Vemurafenib—CYP1A2—hematopoietic system—malaria	0.00124	0.0183	CbGeAlD
Vemurafenib—Neuropathy peripheral—Sulfadiazine—malaria	0.00122	0.00843	CcSEcCtD
Vemurafenib—Photosensitivity—Quinidine barbiturate—malaria	0.00121	0.00838	CcSEcCtD
Vemurafenib—Nervous system disorder—Proguanil—malaria	0.00117	0.0081	CcSEcCtD
Vemurafenib—Skin disorder—Proguanil—malaria	0.00116	0.00802	CcSEcCtD
Vemurafenib—Hypersensitivity—Pyrimethamine—malaria	0.00113	0.00781	CcSEcCtD
Vemurafenib—ORM1—liver—malaria	0.00111	0.0164	CbGeAlD
Vemurafenib—Dry skin—Clindamycin—malaria	0.0011	0.00762	CcSEcCtD
Vemurafenib—Toxic epidermal necrolysis—Clindamycin—malaria	0.00108	0.00748	CcSEcCtD
Vemurafenib—Toxic epidermal necrolysis—Quinidine—malaria	0.00106	0.00734	CcSEcCtD
Vemurafenib—Toxic epidermal necrolysis—Quinine—malaria	0.00106	0.00734	CcSEcCtD
Vemurafenib—Erythema multiforme—Sulfadiazine—malaria	0.00106	0.0073	CcSEcCtD
Vemurafenib—Decreased appetite—Proguanil—malaria	0.00104	0.00718	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Proguanil—malaria	0.00103	0.00713	CcSEcCtD
Vemurafenib—Eosinophilia—Clindamycin—malaria	0.00103	0.00711	CcSEcCtD
Vemurafenib—ABCC1—blood—malaria	0.00103	0.0152	CbGeAlD
Vemurafenib—Chills—Sulfadiazine—malaria	0.001	0.00693	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Dapsone—malaria	0.000982	0.00678	CcSEcCtD
Vemurafenib—Vomiting—Pyrimethamine—malaria	0.000977	0.00674	CcSEcCtD
Vemurafenib—ALB—liver—malaria	0.000973	0.0144	CbGeAlD
Vemurafenib—Toxic epidermal necrolysis—Quinidine barbiturate—malaria	0.00096	0.00662	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Clindamycin—malaria	0.00095	0.00655	CcSEcCtD
Vemurafenib—Body temperature increased—Proguanil—malaria	0.000947	0.00653	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Dapsone—malaria	0.00094	0.00649	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Quinidine—malaria	0.000932	0.00643	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Quinine—malaria	0.000932	0.00643	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Clindamycin—malaria	0.00092	0.00635	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Quinidine—malaria	0.000903	0.00623	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Quinine—malaria	0.000903	0.00623	CcSEcCtD
Vemurafenib—CYP3A4—hematopoietic system—malaria	0.000894	0.0132	CbGeAlD
Vemurafenib—CYP2D6—hematopoietic system—malaria	0.00088	0.013	CbGeAlD
Vemurafenib—CYP1A2—digestive system—malaria	0.000859	0.0127	CbGeAlD
Vemurafenib—ABCG2—blood—malaria	0.00085	0.0126	CbGeAlD
Vemurafenib—Photosensitivity reaction—Quinidine barbiturate—malaria	0.000841	0.0058	CcSEcCtD
Vemurafenib—Arthralgia—Sulfadiazine—malaria	0.000829	0.00572	CcSEcCtD
Vemurafenib—ABCG2—bone marrow—malaria	0.000823	0.0122	CbGeAlD
Vemurafenib—Infestation NOS—Pentoxifylline—malaria	0.00082	0.00566	CcSEcCtD
Vemurafenib—Infestation—Pentoxifylline—malaria	0.00082	0.00566	CcSEcCtD
Vemurafenib—Diarrhoea—Proguanil—malaria	0.000819	0.00565	CcSEcCtD
Vemurafenib—CYP1A2—blood—malaria	0.000818	0.0121	CbGeAlD
Vemurafenib—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.000815	0.00562	CcSEcCtD
Vemurafenib—ABCC1—liver—malaria	0.000803	0.0119	CbGeAlD
Vemurafenib—Anaphylactic shock—Sulfadiazine—malaria	0.000795	0.00548	CcSEcCtD
Vemurafenib—Erythema multiforme—Clindamycin—malaria	0.000788	0.00543	CcSEcCtD
Vemurafenib—Erythema multiforme—Quinine—malaria	0.000773	0.00533	CcSEcCtD
Vemurafenib—Erythema multiforme—Quinidine—malaria	0.000773	0.00533	CcSEcCtD
Vemurafenib—ALB—brain—malaria	0.000772	0.0114	CbGeAlD
Vemurafenib—Eye disorder—Quinidine—malaria	0.000764	0.00527	CcSEcCtD
Vemurafenib—Eye disorder—Quinine—malaria	0.000764	0.00527	CcSEcCtD
Vemurafenib—Vomiting—Proguanil—malaria	0.000761	0.00525	CcSEcCtD
Vemurafenib—Cardiac disorder—Quinidine—malaria	0.000759	0.00523	CcSEcCtD
Vemurafenib—Cardiac disorder—Quinine—malaria	0.000759	0.00523	CcSEcCtD
Vemurafenib—Rash—Proguanil—malaria	0.000755	0.00521	CcSEcCtD
Vemurafenib—Dermatitis—Proguanil—malaria	0.000754	0.0052	CcSEcCtD
Vemurafenib—Headache—Proguanil—malaria	0.00075	0.00518	CcSEcCtD
Vemurafenib—Erythema—Dapsone—malaria	0.00075	0.00517	CcSEcCtD
Vemurafenib—Mediastinal disorder—Quinine—malaria	0.000737	0.00508	CcSEcCtD
Vemurafenib—Mediastinal disorder—Quinidine—malaria	0.000737	0.00508	CcSEcCtD
Vemurafenib—Chills—Quinine—malaria	0.000733	0.00506	CcSEcCtD
Vemurafenib—Chills—Quinidine—malaria	0.000733	0.00506	CcSEcCtD
Vemurafenib—CYP3A4—kidney—malaria	0.000733	0.0108	CbGeAlD
Vemurafenib—Erythema—Clindamycin—malaria	0.000725	0.005	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000724	0.005	CcSEcCtD
Vemurafenib—CYP2D6—kidney—malaria	0.000721	0.0107	CbGeAlD
Vemurafenib—Erythema—Quinidine—malaria	0.000711	0.00491	CcSEcCtD
Vemurafenib—Malnutrition—Quinidine—malaria	0.000711	0.00491	CcSEcCtD
Vemurafenib—Malnutrition—Quinine—malaria	0.000711	0.00491	CcSEcCtD
Vemurafenib—Erythema—Quinine—malaria	0.000711	0.00491	CcSEcCtD
Vemurafenib—Nausea—Proguanil—malaria	0.000711	0.00491	CcSEcCtD
Vemurafenib—Dysgeusia—Clindamycin—malaria	0.00071	0.0049	CcSEcCtD
Vemurafenib—Back pain—Clindamycin—malaria	0.000702	0.00484	CcSEcCtD
Vemurafenib—Erythema multiforme—Quinidine barbiturate—malaria	0.000697	0.00481	CcSEcCtD
Vemurafenib—Decreased appetite—Sulfadiazine—malaria	0.000691	0.00477	CcSEcCtD
Vemurafenib—Eye disorder—Quinidine barbiturate—malaria	0.000689	0.00476	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000686	0.00473	CcSEcCtD
Vemurafenib—Cardiac disorder—Quinidine barbiturate—malaria	0.000685	0.00472	CcSEcCtD
Vemurafenib—ABCG2—liver—malaria	0.000665	0.00983	CbGeAlD
Vemurafenib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000665	0.00459	CcSEcCtD
Vemurafenib—Chills—Quinidine barbiturate—malaria	0.000662	0.00457	CcSEcCtD
Vemurafenib—Cough—Dapsone—malaria	0.000654	0.00451	CcSEcCtD
Vemurafenib—Malnutrition—Quinidine barbiturate—malaria	0.000642	0.00443	CcSEcCtD
Vemurafenib—Erythema—Quinidine barbiturate—malaria	0.000642	0.00443	CcSEcCtD
Vemurafenib—Erythema—Pentoxifylline—malaria	0.000641	0.00442	CcSEcCtD
Vemurafenib—CYP1A2—liver—malaria	0.00064	0.00946	CbGeAlD
Vemurafenib—ABCC1—brain—malaria	0.000637	0.00942	CbGeAlD
Vemurafenib—Body temperature increased—Sulfadiazine—malaria	0.000628	0.00433	CcSEcCtD
Vemurafenib—Dysgeusia—Pentoxifylline—malaria	0.000628	0.00433	CcSEcCtD
Vemurafenib—CYP3A4—digestive system—malaria	0.000622	0.00919	CbGeAlD
Vemurafenib—Back pain—Pentoxifylline—malaria	0.00062	0.00428	CcSEcCtD
Vemurafenib—CYP2D6—digestive system—malaria	0.000612	0.00904	CbGeAlD
Vemurafenib—Myalgia—Quinine—malaria	0.000606	0.00418	CcSEcCtD
Vemurafenib—Myalgia—Quinidine—malaria	0.000606	0.00418	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000602	0.00415	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000602	0.00415	CcSEcCtD
Vemurafenib—CYP3A4—blood—malaria	0.000592	0.00875	CbGeAlD
Vemurafenib—Anaphylactic shock—Clindamycin—malaria	0.000592	0.00408	CcSEcCtD
Vemurafenib—Hypersensitivity—Sulfadiazine—malaria	0.000586	0.00404	CcSEcCtD
Vemurafenib—CYP2D6—blood—malaria	0.000583	0.00861	CbGeAlD
Vemurafenib—Nervous system disorder—Quinidine—malaria	0.000569	0.00393	CcSEcCtD
Vemurafenib—Nervous system disorder—Quinine—malaria	0.000569	0.00393	CcSEcCtD
Vemurafenib—Skin disorder—Quinidine—malaria	0.000564	0.00389	CcSEcCtD
Vemurafenib—Skin disorder—Quinine—malaria	0.000564	0.00389	CcSEcCtD
Vemurafenib—Pruritus—Sulfadiazine—malaria	0.000562	0.00388	CcSEcCtD
Vemurafenib—Hypotension—Clindamycin—malaria	0.000553	0.00382	CcSEcCtD
Vemurafenib—Myalgia—Quinidine barbiturate—malaria	0.000547	0.00377	CcSEcCtD
Vemurafenib—Arthralgia—Quinidine barbiturate—malaria	0.000547	0.00377	CcSEcCtD
Vemurafenib—Myalgia—Pentoxifylline—malaria	0.000546	0.00376	CcSEcCtD
Vemurafenib—Diarrhoea—Sulfadiazine—malaria	0.000544	0.00375	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000543	0.00375	CcSEcCtD
Vemurafenib—Hypotension—Quinidine—malaria	0.000543	0.00374	CcSEcCtD
Vemurafenib—Hypotension—Quinine—malaria	0.000543	0.00374	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000542	0.00374	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Quinine—malaria	0.000529	0.00365	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Quinidine—malaria	0.000529	0.00365	CcSEcCtD
Vemurafenib—ABCG2—brain—malaria	0.000528	0.0078	CbGeAlD
Vemurafenib—Anaphylactic shock—Pentoxifylline—malaria	0.000523	0.00361	CcSEcCtD
Vemurafenib—Infection—Pentoxifylline—malaria	0.00052	0.00359	CcSEcCtD
Vemurafenib—Nervous system disorder—Quinidine barbiturate—malaria	0.000514	0.00355	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Clindamycin—malaria	0.000511	0.00353	CcSEcCtD
Vemurafenib—Fatigue—Clindamycin—malaria	0.00051	0.00352	CcSEcCtD
Vemurafenib—Skin disorder—Quinidine barbiturate—malaria	0.000509	0.00351	CcSEcCtD
Vemurafenib—Skin disorder—Pentoxifylline—malaria	0.000508	0.00351	CcSEcCtD
Vemurafenib—Constipation—Clindamycin—malaria	0.000506	0.00349	CcSEcCtD
Vemurafenib—Vomiting—Sulfadiazine—malaria	0.000505	0.00349	CcSEcCtD
Vemurafenib—Decreased appetite—Quinidine—malaria	0.000505	0.00348	CcSEcCtD
Vemurafenib—Decreased appetite—Quinine—malaria	0.000505	0.00348	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Quinine—malaria	0.000501	0.00346	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Quinidine—malaria	0.000501	0.00346	CcSEcCtD
Vemurafenib—Rash—Sulfadiazine—malaria	0.000501	0.00346	CcSEcCtD
Vemurafenib—Dermatitis—Sulfadiazine—malaria	0.000501	0.00345	CcSEcCtD
Vemurafenib—Headache—Sulfadiazine—malaria	0.000498	0.00344	CcSEcCtD
Vemurafenib—Hypotension—Quinidine barbiturate—malaria	0.00049	0.00338	CcSEcCtD
Vemurafenib—Hypotension—Pentoxifylline—malaria	0.000489	0.00337	CcSEcCtD
Vemurafenib—Body temperature increased—Dapsone—malaria	0.000484	0.00334	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000477	0.00329	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000477	0.00329	CcSEcCtD
Vemurafenib—Nausea—Sulfadiazine—malaria	0.000472	0.00326	CcSEcCtD
Vemurafenib—Body temperature increased—Clindamycin—malaria	0.000468	0.00323	CcSEcCtD
Vemurafenib—CYP3A4—liver—malaria	0.000463	0.00685	CbGeAlD
Vemurafenib—Body temperature increased—Quinine—malaria	0.000459	0.00317	CcSEcCtD
Vemurafenib—Body temperature increased—Quinidine—malaria	0.000459	0.00317	CcSEcCtD
Vemurafenib—CYP2D6—liver—malaria	0.000456	0.00674	CbGeAlD
Vemurafenib—Decreased appetite—Quinidine barbiturate—malaria	0.000456	0.00314	CcSEcCtD
Vemurafenib—Decreased appetite—Pentoxifylline—malaria	0.000455	0.00314	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000452	0.00312	CcSEcCtD
Vemurafenib—Constipation—Quinidine barbiturate—malaria	0.000448	0.00309	CcSEcCtD
Vemurafenib—Constipation—Pentoxifylline—malaria	0.000447	0.00309	CcSEcCtD
Vemurafenib—Hypersensitivity—Clindamycin—malaria	0.000436	0.00301	CcSEcCtD
Vemurafenib—Hypersensitivity—Quinidine—malaria	0.000428	0.00295	CcSEcCtD
Vemurafenib—Hypersensitivity—Quinine—malaria	0.000428	0.00295	CcSEcCtD
Vemurafenib—Asthenia—Clindamycin—malaria	0.000425	0.00293	CcSEcCtD
Vemurafenib—Pruritus—Clindamycin—malaria	0.000419	0.00289	CcSEcCtD
Vemurafenib—Asthenia—Quinidine—malaria	0.000417	0.00287	CcSEcCtD
Vemurafenib—Asthenia—Quinine—malaria	0.000417	0.00287	CcSEcCtD
Vemurafenib—Body temperature increased—Quinidine barbiturate—malaria	0.000414	0.00286	CcSEcCtD
Vemurafenib—Body temperature increased—Pentoxifylline—malaria	0.000414	0.00285	CcSEcCtD
Vemurafenib—Pruritus—Quinine—malaria	0.000411	0.00283	CcSEcCtD
Vemurafenib—Pruritus—Quinidine—malaria	0.000411	0.00283	CcSEcCtD
Vemurafenib—Diarrhoea—Clindamycin—malaria	0.000405	0.00279	CcSEcCtD
Vemurafenib—Diarrhoea—Quinine—malaria	0.000397	0.00274	CcSEcCtD
Vemurafenib—Diarrhoea—Quinidine—malaria	0.000397	0.00274	CcSEcCtD
Vemurafenib—Dizziness—Clindamycin—malaria	0.000391	0.0027	CcSEcCtD
Vemurafenib—Vomiting—Dapsone—malaria	0.000389	0.00268	CcSEcCtD
Vemurafenib—Hypersensitivity—Quinidine barbiturate—malaria	0.000386	0.00266	CcSEcCtD
Vemurafenib—Hypersensitivity—Pentoxifylline—malaria	0.000385	0.00266	CcSEcCtD
Vemurafenib—Dizziness—Quinidine—malaria	0.000384	0.00265	CcSEcCtD
Vemurafenib—Dizziness—Quinine—malaria	0.000384	0.00265	CcSEcCtD
Vemurafenib—Headache—Dapsone—malaria	0.000383	0.00264	CcSEcCtD
Vemurafenib—Vomiting—Clindamycin—malaria	0.000376	0.0026	CcSEcCtD
Vemurafenib—Asthenia—Quinidine barbiturate—malaria	0.000376	0.00259	CcSEcCtD
Vemurafenib—Asthenia—Pentoxifylline—malaria	0.000375	0.00259	CcSEcCtD
Vemurafenib—Rash—Clindamycin—malaria	0.000373	0.00257	CcSEcCtD
Vemurafenib—Dermatitis—Clindamycin—malaria	0.000373	0.00257	CcSEcCtD
Vemurafenib—Headache—Clindamycin—malaria	0.000371	0.00256	CcSEcCtD
Vemurafenib—Pruritus—Quinidine barbiturate—malaria	0.000371	0.00256	CcSEcCtD
Vemurafenib—Pruritus—Pentoxifylline—malaria	0.00037	0.00255	CcSEcCtD
Vemurafenib—Vomiting—Quinidine—malaria	0.000369	0.00255	CcSEcCtD
Vemurafenib—Vomiting—Quinine—malaria	0.000369	0.00255	CcSEcCtD
Vemurafenib—Rash—Quinidine—malaria	0.000366	0.00253	CcSEcCtD
Vemurafenib—Rash—Quinine—malaria	0.000366	0.00253	CcSEcCtD
Vemurafenib—Dermatitis—Quinidine—malaria	0.000366	0.00252	CcSEcCtD
Vemurafenib—Dermatitis—Quinine—malaria	0.000366	0.00252	CcSEcCtD
Vemurafenib—Headache—Quinine—malaria	0.000364	0.00251	CcSEcCtD
Vemurafenib—Headache—Quinidine—malaria	0.000364	0.00251	CcSEcCtD
Vemurafenib—Nausea—Dapsone—malaria	0.000363	0.00251	CcSEcCtD
Vemurafenib—CYP2D6—brain—malaria	0.000362	0.00535	CbGeAlD
Vemurafenib—Diarrhoea—Quinidine barbiturate—malaria	0.000359	0.00247	CcSEcCtD
Vemurafenib—Diarrhoea—Pentoxifylline—malaria	0.000358	0.00247	CcSEcCtD
Vemurafenib—Nausea—Clindamycin—malaria	0.000352	0.00243	CcSEcCtD
Vemurafenib—Dizziness—Quinidine barbiturate—malaria	0.000347	0.00239	CcSEcCtD
Vemurafenib—Dizziness—Pentoxifylline—malaria	0.000346	0.00239	CcSEcCtD
Vemurafenib—Nausea—Quinine—malaria	0.000345	0.00238	CcSEcCtD
Vemurafenib—Nausea—Quinidine—malaria	0.000345	0.00238	CcSEcCtD
Vemurafenib—Vomiting—Quinidine barbiturate—malaria	0.000333	0.0023	CcSEcCtD
Vemurafenib—Vomiting—Pentoxifylline—malaria	0.000333	0.00229	CcSEcCtD
Vemurafenib—Rash—Quinidine barbiturate—malaria	0.00033	0.00228	CcSEcCtD
Vemurafenib—Dermatitis—Quinidine barbiturate—malaria	0.00033	0.00228	CcSEcCtD
Vemurafenib—Rash—Pentoxifylline—malaria	0.00033	0.00228	CcSEcCtD
Vemurafenib—Dermatitis—Pentoxifylline—malaria	0.00033	0.00227	CcSEcCtD
Vemurafenib—Headache—Quinidine barbiturate—malaria	0.000328	0.00226	CcSEcCtD
Vemurafenib—Headache—Pentoxifylline—malaria	0.000328	0.00226	CcSEcCtD
Vemurafenib—Nausea—Quinidine barbiturate—malaria	0.000311	0.00215	CcSEcCtD
Vemurafenib—Nausea—Pentoxifylline—malaria	0.000311	0.00214	CcSEcCtD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC4A1—malaria	0.000163	0.00249	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—CRP—malaria	0.000158	0.00242	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—TIRAP—malaria	0.000158	0.00242	CbGpPWpGaD
Vemurafenib—RAF1—TCR Signaling Pathway—CD4—malaria	0.000155	0.00237	CbGpPWpGaD
Vemurafenib—RAF1—TWEAK Signaling Pathway—IL6—malaria	0.000154	0.00236	CbGpPWpGaD
Vemurafenib—RAF1—Cardiac Hypertrophic Response—TNF—malaria	0.000154	0.00236	CbGpPWpGaD
Vemurafenib—RAF1—FCERI mediated MAPK activation—IL6—malaria	0.000151	0.00232	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—HLA-B—malaria	0.000151	0.00231	CbGpPWpGaD
Vemurafenib—ALB—Platelet degranulation—CD36—malaria	0.000151	0.0023	CbGpPWpGaD
Vemurafenib—RAF1—FRS2-mediated cascade—IL6—malaria	0.000149	0.00228	CbGpPWpGaD
Vemurafenib—RAF1—Signalling to ERKs—IL6—malaria	0.000149	0.00228	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—FAS—malaria	0.000149	0.00227	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CR1—malaria	0.000147	0.00225	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—ICAM1—malaria	0.000146	0.00223	CbGpPWpGaD
Vemurafenib—ALB—Response to elevated platelet cytosolic Ca2+—CD36—malaria	0.000144	0.0022	CbGpPWpGaD
Vemurafenib—RAF1—TCR Signaling Pathway—IL1B—malaria	0.000143	0.00219	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—IFNG—malaria	0.000142	0.00217	CbGpPWpGaD
Vemurafenib—RAF1—Interleukin-2 signaling—IL6—malaria	0.000141	0.00216	CbGpPWpGaD
Vemurafenib—RAF1—Corticotropin-releasing hormone—IL2—malaria	0.00014	0.00215	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—IFNG—malaria	0.000136	0.00208	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000134	0.00205	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling in naïve CD8+ T cells—TNF—malaria	0.000133	0.00204	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—IL1B—malaria	0.000127	0.00194	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—CRP—malaria	0.000126	0.00193	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—IL1B—malaria	0.000126	0.00192	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—TLR9—malaria	0.000125	0.00191	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—CD36—malaria	0.000124	0.0019	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—IL1B—malaria	0.000124	0.00189	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—IL2—malaria	0.000123	0.00189	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—IL1B—malaria	0.000121	0.00186	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—KDR—malaria	0.000121	0.00185	CbGpPWpGaD
Vemurafenib—RAF1—SHP2 signaling—IL6—malaria	0.000119	0.00182	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—HPGDS—malaria	0.000117	0.00179	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—ICAM1—malaria	0.000116	0.00177	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PKLR—malaria	0.000114	0.00175	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—IFNG—malaria	0.000111	0.0017	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL18—malaria	0.000111	0.00169	CbGpPWpGaD
Vemurafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TNF—malaria	0.00011	0.00168	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CISH—malaria	0.00011	0.00168	CbGpPWpGaD
Vemurafenib—BRAF—Senescence and Autophagy in Cancer—IL6—malaria	0.000107	0.00164	CbGpPWpGaD
Vemurafenib—RAF1—NCAM signaling for neurite out-growth—IL6—malaria	0.000105	0.00161	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—HLA-B—malaria	0.000105	0.0016	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000103	0.00158	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FCGR2B—malaria	0.000103	0.00158	CbGpPWpGaD
Vemurafenib—RAF1—TNF alpha Signaling Pathway—TNF—malaria	0.000102	0.00156	CbGpPWpGaD
Vemurafenib—BRAF—Disease—G6PD—malaria	0.000102	0.00156	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—DHODH—malaria	0.000102	0.00156	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC4A1—malaria	0.0001	0.00154	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.0001	0.00153	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—FCGR2A—malaria	0.0001	0.00153	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—DECR1—malaria	9.93e-05	0.00152	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—HPGDS—malaria	9.91e-05	0.00152	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—ACKR1—malaria	9.89e-05	0.00151	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—IL1B—malaria	9.88e-05	0.00151	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—HBB—malaria	9.87e-05	0.00151	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—IL2—malaria	9.85e-05	0.00151	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	9.23e-05	0.00141	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—TIRAP—malaria	9.22e-05	0.00141	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—SCARB1—malaria	9.2e-05	0.00141	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	9.19e-05	0.00141	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—TNF—malaria	9.12e-05	0.0014	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—DHODH—malaria	8.97e-05	0.00137	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—TNF—malaria	8.81e-05	0.00135	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—IFNG—malaria	8.8e-05	0.00135	CbGpPWpGaD
Vemurafenib—RAF1—IRS-mediated signalling—IL6—malaria	8.78e-05	0.00134	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—IL1B—malaria	8.7e-05	0.00133	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—SLC4A1—malaria	8.67e-05	0.00133	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CR1—malaria	8.57e-05	0.00131	CbGpPWpGaD
Vemurafenib—RAF1—IRS-related events—IL6—malaria	8.54e-05	0.00131	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—ICAM1—malaria	8.51e-05	0.0013	CbGpPWpGaD
Vemurafenib—RAF1—IRS-related events triggered by IGF1R—IL6—malaria	8.47e-05	0.0013	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ACKR1—malaria	8.45e-05	0.00129	CbGpPWpGaD
Vemurafenib—RAF1—TCR Signaling Pathway—IL6—malaria	8.39e-05	0.00128	CbGpPWpGaD
Vemurafenib—RAF1—Insulin receptor signalling cascade—IL6—malaria	8.24e-05	0.00126	CbGpPWpGaD
Vemurafenib—RAF1—IGF1R signaling cascade—IL6—malaria	8.24e-05	0.00126	CbGpPWpGaD
Vemurafenib—RAF1—TNF alpha Signaling Pathway—IL6—malaria	8.24e-05	0.00126	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—DECR1—malaria	8.15e-05	0.00125	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PKLR—malaria	7.91e-05	0.00121	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—KDR—malaria	7.9e-05	0.00121	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—IL1B—malaria	7.85e-05	0.0012	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PKLR—malaria	7.84e-05	0.0012	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—HPGDS—malaria	7.65e-05	0.00117	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—SLC4A1—malaria	7.63e-05	0.00117	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—IL6—malaria	7.58e-05	0.00116	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—IL6—malaria	7.42e-05	0.00113	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—HBB—malaria	7.37e-05	0.00113	CbGpPWpGaD
Vemurafenib—RAF1—VEGFA-VEGFR2 Pathway—IL6—malaria	7.31e-05	0.00112	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—TLR9—malaria	7.29e-05	0.00111	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—IL6—malaria	7.25e-05	0.00111	CbGpPWpGaD
Vemurafenib—BRAF—Disease—DHFR—malaria	7.21e-05	0.0011	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TNF—malaria	7.17e-05	0.0011	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—DECR1—malaria	7.17e-05	0.0011	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—IL6—malaria	7.11e-05	0.00109	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—IL6—malaria	7.06e-05	0.00108	CbGpPWpGaD
Vemurafenib—RAF1—Disease—G6PD—malaria	7.05e-05	0.00108	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—G6PD—malaria	6.99e-05	0.00107	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—IL2—malaria	6.96e-05	0.00106	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	6.95e-05	0.00106	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by VEGF—IL6—malaria	6.9e-05	0.00105	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Insulin receptor—IL6—malaria	6.85e-05	0.00105	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TLR9—malaria	6.81e-05	0.00104	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	6.7e-05	0.00102	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	6.7e-05	0.00102	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—CD36—malaria	6.68e-05	0.00102	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PKLR—malaria	6.57e-05	0.001	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—CD36—malaria	6.52e-05	0.000998	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—HBB—malaria	6.48e-05	0.000992	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IFNG—malaria	6.48e-05	0.000991	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—CD36—malaria	6.4e-05	0.000979	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TNF—malaria	6.31e-05	0.000965	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—IL6—malaria	6.25e-05	0.000956	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD40LG—malaria	5.93e-05	0.000908	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—HLA-B—malaria	5.88e-05	0.000899	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD8A—malaria	5.87e-05	0.000897	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—IL6—malaria	5.86e-05	0.000896	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—G6PD—malaria	5.85e-05	0.000896	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ACKR1—malaria	5.84e-05	0.000894	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FCGR2A—malaria	5.82e-05	0.000891	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—IL6—malaria	5.79e-05	0.000885	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PKLR—malaria	5.78e-05	0.000884	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL1B—malaria	5.78e-05	0.000884	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—CD36—malaria	5.78e-05	0.000884	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CD36—malaria	5.76e-05	0.000882	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL2—malaria	5.76e-05	0.000881	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—TNF—malaria	5.7e-05	0.000872	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—malaria	5.69e-05	0.000871	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—HLA-B—malaria	5.64e-05	0.000863	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—KDR—malaria	5.64e-05	0.000863	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—IL6—malaria	5.61e-05	0.000858	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—DHODH—malaria	5.53e-05	0.000847	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD36—malaria	5.53e-05	0.000846	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—IL6—malaria	5.52e-05	0.000844	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—HPGDS—malaria	5.44e-05	0.000833	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—IL6—malaria	5.27e-05	0.000806	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—NOS2—malaria	5.26e-05	0.000805	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—IL6—malaria	5.24e-05	0.000802	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—IL6—malaria	5.22e-05	0.000798	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CRP—malaria	5.19e-05	0.000795	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—IL6—malaria	5.19e-05	0.000794	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—G6PD—malaria	5.15e-05	0.000788	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—SCARB1—malaria	5e-05	0.000764	CbGpPWpGaD
Vemurafenib—RAF1—Disease—DHFR—malaria	4.99e-05	0.000763	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—TLR4—malaria	4.98e-05	0.000762	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—DHFR—malaria	4.95e-05	0.000757	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—IL6—malaria	4.88e-05	0.000747	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—IL6—malaria	4.88e-05	0.000747	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—IL6—malaria	4.88e-05	0.000747	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—IL6—malaria	4.84e-05	0.00074	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—IL6—malaria	4.81e-05	0.000736	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—IL6—malaria	4.8e-05	0.000734	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—IL6—malaria	4.78e-05	0.000731	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TLR9—malaria	4.71e-05	0.000721	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—SLC4A1—malaria	4.71e-05	0.00072	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—IL6—malaria	4.6e-05	0.000703	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—ICAM1—malaria	4.58e-05	0.000701	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—DHODH—malaria	4.57e-05	0.000699	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—HPGDS—malaria	4.46e-05	0.000683	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—DECR1—malaria	4.42e-05	0.000677	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—IL6—malaria	4.33e-05	0.000662	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	4.18e-05	0.000639	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—DHFR—malaria	4.14e-05	0.000634	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—SCARB1—malaria	4.1e-05	0.000627	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—HBB—malaria	4e-05	0.000612	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—HPGDS—malaria	3.93e-05	0.000601	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—SLC4A1—malaria	3.89e-05	0.000594	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—DHODH—malaria	3.87e-05	0.000592	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.81e-05	0.000582	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—IL2—malaria	3.74e-05	0.000573	CbGpPWpGaD
Vemurafenib—BRAF—Disease—NOS2—malaria	3.68e-05	0.000563	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—DECR1—malaria	3.65e-05	0.000559	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—DHFR—malaria	3.64e-05	0.000558	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL18—malaria	3.61e-05	0.000553	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—SCARB1—malaria	3.61e-05	0.000552	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD40LG—malaria	3.6e-05	0.000551	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—IL2—malaria	3.59e-05	0.000549	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PKLR—malaria	3.57e-05	0.000546	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD8A—malaria	3.56e-05	0.000544	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CD4—malaria	3.51e-05	0.000537	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.5e-05	0.000535	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—CD36—malaria	3.44e-05	0.000527	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-B—malaria	3.42e-05	0.000524	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL6—malaria	3.38e-05	0.000518	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD4—malaria	3.37e-05	0.000515	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD36—malaria	3.36e-05	0.000513	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—IL6—malaria	3.33e-05	0.000509	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—HBB—malaria	3.3e-05	0.000505	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SLC4A1—malaria	3.29e-05	0.000504	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—G6PD—malaria	3.18e-05	0.000486	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	3.14e-05	0.00048	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—DECR1—malaria	3.09e-05	0.000473	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CRP—malaria	3.03e-05	0.000463	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—IL6—malaria	3.01e-05	0.000461	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—DHODH—malaria	2.99e-05	0.000457	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PKLR—malaria	2.94e-05	0.00045	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—TLR4—malaria	2.9e-05	0.000444	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—NOS2—malaria	2.83e-05	0.000433	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—HBB—malaria	2.8e-05	0.000428	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ICAM1—malaria	2.78e-05	0.000425	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CD4—malaria	2.73e-05	0.000417	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—KDR—malaria	2.71e-05	0.000415	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TNF—malaria	2.66e-05	0.000407	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—G6PD—malaria	2.62e-05	0.000401	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CD36—malaria	2.57e-05	0.000394	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NOS2—malaria	2.55e-05	0.00039	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SLC4A1—malaria	2.54e-05	0.000389	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NOS2—malaria	2.53e-05	0.000386	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PKLR—malaria	2.49e-05	0.000382	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—HPGDS—malaria	2.42e-05	0.000371	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—DECR1—malaria	2.39e-05	0.000365	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CD36—malaria	2.26e-05	0.000346	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—DHFR—malaria	2.25e-05	0.000344	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—SCARB1—malaria	2.23e-05	0.00034	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—G6PD—malaria	2.22e-05	0.00034	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	2.19e-05	0.000336	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—HBB—malaria	2.16e-05	0.00033	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—IL6—malaria	2.15e-05	0.000329	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IFNG—malaria	2.12e-05	0.000324	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL2—malaria	2.06e-05	0.000315	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD4—malaria	2.04e-05	0.000313	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—HPGDS—malaria	2e-05	0.000306	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IL2—malaria	1.93e-05	0.000295	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PKLR—malaria	1.93e-05	0.000294	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—IL6—malaria	1.9e-05	0.00029	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL1B—malaria	1.89e-05	0.000289	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CD4—malaria	1.89e-05	0.000289	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL2—malaria	1.88e-05	0.000288	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—KDR—malaria	1.88e-05	0.000287	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CD4—malaria	1.87e-05	0.000286	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—DHFR—malaria	1.86e-05	0.000284	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—SCARB1—malaria	1.84e-05	0.000281	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL2—malaria	1.76e-05	0.000269	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—G6PD—malaria	1.72e-05	0.000262	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—HPGDS—malaria	1.7e-05	0.000259	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—DHFR—malaria	1.57e-05	0.000241	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SCARB1—malaria	1.56e-05	0.000238	CbGpPWpGaD
Vemurafenib—BRAF—Disease—IL6—malaria	1.47e-05	0.000226	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CD36—malaria	1.4e-05	0.000214	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—HPGDS—malaria	1.31e-05	0.0002	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL2—malaria	1.22e-05	0.000186	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—DHFR—malaria	1.21e-05	0.000186	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL6—malaria	1.21e-05	0.000185	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SCARB1—malaria	1.2e-05	0.000184	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CD36—malaria	1.15e-05	0.000176	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL6—malaria	1.11e-05	0.000169	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL6—malaria	1.03e-05	0.000158	CbGpPWpGaD
Vemurafenib—RAF1—Disease—IL6—malaria	1.02e-05	0.000156	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—IL6—malaria	1.01e-05	0.000155	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CD36—malaria	9.77e-06	0.000149	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CD36—malaria	7.54e-06	0.000115	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL6—malaria	7.15e-06	0.000109	CbGpPWpGaD
